ICD-11 code : 6C4B.2;
Preferred Label : Volatile inhalant dependence;
ICD-11 definition : Volatile inhalant dependence is a disorder of regulation of volatile inhalant use
arising from repeated or continuous use of volatile inhalants. The characteristic
feature is a strong internal drive to use volatile inhalants, which is manifested
by impaired ability to control use, increasing priority given to use over other activities
and persistence of use despite harm or negative consequences. These experiences are
often accompanied by a subjective sensation of urge or craving to use volatile inhalants.
Physiological features of dependence may also be present, including tolerance to the
effects of volatile inhalants, withdrawal symptoms following cessation or reduction
in use of volatile inhalants, or repeated use of volatile inhalants or pharmacologically
similar substances to prevent or alleviate withdrawal symptoms. The features of dependence
are usually evident over a period of at least 12 months but the diagnosis may be made
if volatile inhalant use is continuous (daily or almost daily) for at least 1 month.;
ICD-11 synonym : Volatile inhalant addiction;
ICD-11 inclusion : glue sniffing addiction; glue sniffing dependence;
ICD-11 "unspecified" category code : 6C4B.2Z;
Origin ID : 734634730;
Currated CISMeF NLP mapping
- ICD-10 Mapping
Volatile inhalant dependence is a disorder of regulation of volatile inhalant use
arising from repeated or continuous use of volatile inhalants. The characteristic
feature is a strong internal drive to use volatile inhalants, which is manifested
by impaired ability to control use, increasing priority given to use over other activities
and persistence of use despite harm or negative consequences. These experiences are
often accompanied by a subjective sensation of urge or craving to use volatile inhalants.
Physiological features of dependence may also be present, including tolerance to the
effects of volatile inhalants, withdrawal symptoms following cessation or reduction
in use of volatile inhalants, or repeated use of volatile inhalants or pharmacologically
similar substances to prevent or alleviate withdrawal symptoms. The features of dependence
are usually evident over a period of at least 12 months but the diagnosis may be made
if volatile inhalant use is continuous (daily or almost daily) for at least 1 month.
